Literature DB >> 10518542

BRCA1-associated growth arrest is RB-dependent.

O N Aprelikova1, B S Fang, E G Meissner, S Cotter, M Campbell, A Kuthiala, M Bessho, R A Jensen, E T Liu.   

Abstract

BRCA1 is a susceptibility gene for breast and ovarian cancer with growth-inhibitory activity for which the mechanism of action remains unclear. When introduced into cells, BRCA1 inhibits growth of some but not all cell lines. In an attempt to uncover the mechanism of growth suppression by BRCA1, we examined a panel of cell lines for their ability to reduce colony outgrowth in response to BRCA1 overexpression. Of all variables tested, only those cells with wild-type pRb were sensitive to BRCA1-induced growth suppression. In cells with an intact rb gene, inactivation of pRb by HPV E7 abrogates the growth arrest imposed by BRCA1. In accordance with these observations, we found that BRCA1 could not suppress BrdUrd uptake in primary fibroblasts from rb-/- mice and exhibited an intermediate ability to inhibit DNA synthesis in rb+/- as compared with rb+/+ cells. We further found that the BRCA1 protein complexes with the hypophosphorylated form of pRb. This binding is localized to amino acids 304-394 of BRCA1 protein and requires the ABC domain of pRb. In-frame deletion of BRCA1 fragment involved in interaction with pRb completely abolished the growth-suppressive property of BRCA1. Although it has been reported that BRCA1 interacts with p53, we find the p53 status did not affect the ability of BRCA1 to suppress colony formation. Our data suggest that the growth suppressor function of BRCA1 depends, at least in part, on Rb.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518542      PMCID: PMC18378          DOI: 10.1073/pnas.96.21.11866

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.

Authors:  C Y Liu; A Flesken-Nikitin; S Li; Y Zeng; W H Lee
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

2.  Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins.

Authors:  N Dyson; P Guida; K Münger; E Harlow
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Functional analysis at the Cys706 residue of the retinoblastoma protein.

Authors:  R A Kratzke; G A Otterson; A Y Lin; E Shimizu; N Alexandrova; M Zajac-Kaye; J M Horowitz; F J Kaye
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

4.  BRCA1 physically associates with p53 and stimulates its transcriptional activity.

Authors:  H Zhang; K Somasundaram; Y Peng; H Tian; H Zhang; D Bi; B L Weber; W S El-Deiry
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

5.  Transcriptional activation by BRCA1.

Authors:  M S Chapman; I M Verma
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

6.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

Authors:  K Somasundaram; H Zhang; Y X Zeng; Y Houvras; Y Peng; H Zhang; G S Wu; J D Licht; B L Weber; W S El-Deiry
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

7.  Hormone-dependent regulation of BRCA1 in human breast cancer cells.

Authors:  J M Gudas; H Nguyen; T Li; K H Cowan
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

8.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

9.  Growth retardation and tumour inhibition by BRCA1.

Authors:  J T Holt; M E Thompson; C Szabo; C Robinson-Benion; C L Arteaga; M C King; R A Jensen
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

10.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more
  46 in total

1.  pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F.

Authors:  L Fajas; C Paul; O Zugasti; L Le Cam; J Polanowska; E Fabbrizio; R Medema; M L Vignais; C Sardet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.

Authors:  L J Huber; T W Yang; C J Sarkisian; S R Master; C X Deng; L A Chodosh
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

4.  Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.

Authors:  Yunlong Qin; Jingyao Xu; Kartik Aysola; Nurjahan Begum; Vaishali Reddy; Yuli Chai; William E Grizzle; Edward E Partridge; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

5.  BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

Authors:  Paola De Luca; Elba S Vazquez; Cristian P Moiola; Florencia Zalazar; Javier Cotignola; Geraldine Gueron; Kevin Gardner; Adriana De Siervi
Journal:  Mol Cancer Res       Date:  2011-06-23       Impact factor: 5.852

6.  The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.

Authors:  Hai Xiao; David W Goodrich
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

7.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Authors:  Jia Yun Zhu; Thorsten Pfuhl; Natalie Motsch; Stephanie Barth; John Nicholls; Friedrich Grässer; Gunter Meister
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

9.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

10.  Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.

Authors:  Katherine V Clark-Knowles; Mary K Senterman; Olga Collins; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.